IFNG and inflammatory bowel disease: Levels of IFNγ are often elevated locally and systemically in chronic inflammatory diseases, including IBD, resulting in disruption of intestinal barrier function accompanied by decreased expression of the tight junction molecules ZO-1 and occluding (Smyth et al., 2011).